Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite
Completed · Phase 4
Conditions studied: Edematous Fibrosclerotic Panniculopathy (EFP), Cellulite
In brief
This study will investigate treatments that may mitigate bruising after QWO™ (Collagenase clostridium histolyticum \[CCH\]-aaes) treatment of cellulite in the buttocks.
Key facts
- Study ID
- NCT04677712
- Run by
- Endo USA Inc., a Keenova Therapeutics Company
- People needed
- 48
- Starts
- 2020-12-28
- Expected to finish
- 2021-09-02
- Last updated by the study team
- 2023-08-21
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.
Where it is running
- Endo Clinical Trial Site #3 — Scottsdale, Arizona, United States
- Endo Clinical Trial Site #2 — Sacramento, California, United States
- Endo Clinical Trial Site #7 — San Diego, California, United States
- Endo Clinical Trial Site #6 — Fort Collins, Colorado, United States
- Endo Clinical Trial Site #5 — Chicago, Illinois, United States
- Endo Clinical Trial Site #1 — Shreveport, Louisiana, United States
- Endo Clinical Trial Site #8 — Boston, Massachusetts, United States
- Endo Clinical Trial Site #4 — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.